Utilization and Outcomes of Primary Prevention Implantable Cardioverter‐Defibrillators in Patients With Hypertrophic Cardiomyopathy

BACKGROUND: There is uncertainty about the appropriate use of primary prevention implantable cardioverter‐defibrillators (ICDs) among older patients with hypertrophic cardiomyopathy. METHODS AND RESULTS: Patients with hypertrophic cardiomyopathy who received a primary prevention ICD between 2010 and...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldstein, Sarah A., Kennedy, Kevin F., Friedman, Daniel J., Al‐Khatib, Sana M., Wang, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492935/
https://www.ncbi.nlm.nih.gov/pubmed/37586066
http://dx.doi.org/10.1161/JAHA.122.029293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492935/
https://www.ncbi.nlm.nih.gov/pubmed/37586066
http://dx.doi.org/10.1161/JAHA.122.029293

Ejemplares similares